Market Neuron Logo
โš  Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

ABBOTINDIA - Technical Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Back to Technical List

Technical Rating: 3.9

Hereโ€™s a detailed technical breakdown of ABBOTINDIA

๐Ÿ“Š Trend Analysis

Current Price: โ‚น33,595 is slightly above the 50-DMA (โ‚น33,171) and well above the 200-DMA (โ‚น30,606), indicating a medium-term uptrend.

RSI (47.8): Neutral zone, suggesting lack of strong momentum either way.

MACD (281): Positive, but not sharply diverging, indicating mild bullish momentum.

Volume: Below 1-week average (7,528 vs 9,289), showing low participation and possible consolidation.

๐Ÿ“Œ Conclusion: The stock is consolidating near its upper range after a strong rally. No signs of reversal yet.

๐Ÿ“ˆ Chart Patterns & Indicators

Bollinger Bands: Price is near the middle band, suggesting no breakout pressure.

Candlestick Patterns: Recent formations show indecision, with Doji and Harami patterns appearing on shorter timeframes

1

.

Support Levels

โ‚น33,171 (50-DMA)

โ‚น32,040 (Pivot S1)

2

Resistance Levels

โ‚น34,466 (Pivot R1)

โ‚น37,000 (52-week high)

๐ŸŽฏ Entry & Exit Zones

Action Price Zone (โ‚น) Rationale

Buy Entry 32,000 โ€“ 33,200 Near support, low RSI, consolidation

Target 1 34,500 First resistance zone

Target 2 36,800 โ€“ 37,000 52-week high zone

Stop Loss 31,500 Below 200-DMA and key support

๐Ÿ” Momentum Signals

Short-Term: Weak momentum, neutral RSI, low volume.

Medium-Term: Bullish bias supported by MACD and moving averages.

Long-Term: Strong fundamentals (ROCE 46.2%, ROE 35.7%) and low debt (0.05) support sustained growth.

๐Ÿงญ Final Take

ABBOTINDIA is consolidating with a bullish undertone. A breakout above โ‚น34,500 with volume confirmation could trigger a fresh rally. Until then, accumulation near โ‚น32,000โ€“โ‚น33,200 may offer a favorable risk-reward setup.

Want to explore similar setups in the pharma sector or dive into fundamental valuation next?

1

in.investing.com

2

www.moneycontrol.com

Edit in a page

Back to Technical List